Preclinical evidence for the use of anti-Trop-2 antibody-drug conjugate Sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancer.
Cancer medicine
View this publicationCancer medicine
View this publicationNature communications
View this publicationEuropean urology
View this publicationEuropean journal of cancer (Oxford, England : 1990)
View this publicationJournal of clinical oncology : official journal of the American Society of Clinical Oncology
View this publicationNature immunology
View this publicationLung cancer (Amsterdam, Netherlands)
View this publicationPublication categories: Top publication
Science immunology
View this publicationAmerican journal of translational research
View this publicationHistopathology
View this publication